CIK 0001788028
- Non-accelerated filer
- Smaller reporting company
Jasper Therapeutics, Inc.
Sign in to watch- Ticker
- JSPR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 842984849
- Phone
- +1 650-549-1400
- Business address
- 2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
- Former names
- Amplitude Healthcare Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-13 | GLAZER CAPITAL, LLC 10% owner | Sale | −1,699 | $9.99 | $17K | 1,118,432 |
| 2020-01-03 | VENKATARAMAN BALAJI Chief Executive Officer | Other disposition · Class B Common Stock | −375,000 | 2,500,000 | ||
| 2020-01-03 | HOFFEN HOWARD I Director | Other disposition · Class B Common Stock | −375,000 | 2,500,000 | ||
| 2020-01-03 | Clifford Kenneth F Chief Financial Officer | Other disposition · Class B Common Stock | −375,000 | 2,500,000 | ||
| 2020-01-03 | Amplitude Healthcare Holdings LLC 10% owner | Other disposition · Class B Common Stock | −375,000 | 2,500,000 |
Page 9 of 9 · 165 trades